OnKure Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell OKUR and other ETFs, options, and stocks.About OKUR
OnKure Therapeutics, Inc. engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure and computational chemistry driven drug design platform, committed to improving clinical outcomes for patients by building a robust pipeline of small molecule drugs designed to selectively target specific mutations thought to be key drivers of cancer.
CEONicholas A. Saccomano
CEONicholas A. Saccomano
Employees46
Employees46
HeadquartersBoulder, Colorado
HeadquartersBoulder, Colorado
Founded
Founded
Employees46
Employees46
OKUR Key Statistics
Market cap43.35M
Market cap43.35M
Price-Earnings ratio-0.50
Price-Earnings ratio-0.50
Dividend yield—
Dividend yield—
Average volume209.40K
Average volume209.40K
High today$3.27
High today$3.27
Low today$2.93
Low today$2.93
Open price$3.07
Open price$3.07
Volume120.38K
Volume120.38K
52 Week high$11.00
52 Week high$11.00
52 Week low$1.70
52 Week low$1.70
Stock Snapshot
With a market cap of 43.35M, OnKure Therapeutics(OKUR) trades at $3.20. The stock has a price-to-earnings ratio of -0.50.
On 2025-12-15, OnKure Therapeutics(OKUR) stock moved within a range of $2.93 to $3.27. With shares now at $3.20, the stock is trading +9.4% above its intraday low and -2.1% below the session's peak.
Trading activity shows a volume of 120.38K, compared to an average daily volume of 209.4K.
Over the past 52 weeks, OnKure Therapeutics(OKUR) stock has traded between a high of $11.00 and a low of $1.70.
Over the past 52 weeks, OnKure Therapeutics(OKUR) stock has traded between a high of $11.00 and a low of $1.70.
People also own
Based on the portfolios of people who own OKUR. This list is generated using Robinhood data, and it’s not a recommendation.